SARS, MERS and COVID-19 status in HIV-Positive Patients: A Systematic Review: SARS, MERS and COVID-19 in HIV-positive patients

authors:

avatar M Dolatian 1 , * , avatar Nasrin Ghiasi 2 , avatar Rohollah Valizadeh 3 , avatar Steven James Kellner 4 , avatar Zohreh Mahmoodi ORCID 5 , avatar Mohammad Nanbakhsh 6

Department of Reproductive Health midwifery, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Department of Midwifery, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran
Student Research Committee, Department of Epidemiology, School of Public Health, Iran University of Medical Sciences, Tehran, Iran
Mesencell Biotech International, Garth Business Centre, 193 Garth Road, Morden, United Kingdom
Social Determinants of Health Research Center, Alborz University of Medical Sciences, Karaj, Iran
MD. Assistant Professor of Pediatrics Pulmonology, Shahid Motahari Hospital, Urmia University of Medical Sciences, Urmia, Iran

how to cite: Dolatian M, Ghiasi N, Valizadeh R, Kellner S J, Mahmoodi Z, et al. SARS, MERS and COVID-19 status in HIV-Positive Patients: A Systematic Review: SARS, MERS and COVID-19 in HIV-positive patients. J Cell Mol Anesth. 2021;6(1):e149655. https://doi.org/10.22037/jcma.v6i1.32203.

Abstract

Coronavirus can cause lots of viral diseases such as the common cold, Middle East respiratory Syndrome coronavirus (MERS-CoV), Severe acute respiratory?syndrome?coronavirus? (SARS-CoV) and Coronavirus disease 2019 (COVID-19). Coronavirus and Human immunodeficiency virus?? (HIV) are considered as RNA viruses.The use of antivials in HIV-positive patients chalenges the development and the treatment of the patients with SARA, MERS and COVID-19. We reviewed the relevant studies in this regard to identify SARS, MERS and COVID-19 status in HIV-positive patients.